Mithun Raje

Mithun Raje

Auto-generated profile, based on publicly available information

Mithun Raje

Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine St., Baltimore, MD 21201, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
CRCamilo Rojas
Camilo Rojas
MRMithun Raje
Mithun Raje
TTTakashi Tsukamoto
Takashi Tsukamoto
BSBarbara S. Slusher
Barbara S. Slusher

12 September 2012 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
YKYugesh Kharel
Yugesh Kharel
MRMithun Raje
Mithun Raje
MGMing Gao
Ming Gao
AGAmanda M. Gellett
Amanda M. Gellett
JTJose L. Tomsig
Jose L. Tomsig
WSWebster L. Santos
Webster L. Santos
S1P (sphingosine 1-phosphate) is a pleiotropic lipid mediator involved in numerous cellular and physiological functions. Of note among these are cell survival and migration, as well as lymphocyte trafficking. S1P, which exerts its effects via five GPCRs (G-protein-coupled receptors) (S1P1–S1P5), is formed by the action of two SphKs (sphingosine kinases). Although SphK1 is the more intensively studied isotype, SphK2 is unique in it nuclear localization and has been reported to oppose some of the actions ascribed to SphK1. Although several scaffolds of SphK1 inhibitors have been described, there is a scarcity of selective SphK2 inhibitors that are necessary to evaluate the downstream effects of inhibition of this isotype. In the present paper we report a cationic amphiphilic small molecule that is a selective SphK2 inhibitor. In the course of characterizing this compound in wild-type and SphK-null mice, we discovered that administration of the inhibitor to wild-type mice resulted in a rapid increase in blood S1P, which is in contrast with our SphK1 inhibitor that drives circulating S1P levels down. Using a cohort of F2 hybrid mice, we confirmed, compared with wild-type mice, that circulating S1P levels were higher in SphK2-null mice and lower in SphK1-null mice. Thus both SphK1 and SphK2 inhibitors recapitulate the blood S1P levels observed in the corresponding null mice. Moreover, circulating S1P levels mirror SphK2 inhibitor levels, providing a convenient biomarker of target engagement.

2 June 2015 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
LCLijia Chen
Lijia Chen
JYJeremy L. Yap
Jeremy L. Yap
MYMakoto Yoshioka
Makoto Yoshioka
MLMaryanna E. Lanning
Maryanna E. Lanning
RFRachel N. Fountain
Rachel N. Fountain
SFSteven Fletcher
Steven Fletcher

2 February 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NPNeeraj N. Patwardhan
Neeraj N. Patwardhan
EMEmily A. Morris
Emily A. Morris
YKYugesh Kharel
Yugesh Kharel
MRMithun R. Raje
Mithun R. Raje
MGMing Gao
Ming Gao
WSWebster L. Santos
Webster L. Santos

1 January 2012 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MRMithun R. Raje
Mithun R. Raje
KKKenneth Knott
Kenneth Knott
YKYugesh Kharel
Yugesh Kharel
PBPhilippe Bissel
Philippe Bissel
KLKevin R. Lynch
Kevin R. Lynch
WSWebster L. Santos
Webster L. Santos

1 June 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MYMary K. Yates
Mary K. Yates
MRMithun R. Raje
Mithun R. Raje
PCPayel Chatterjee
Payel Chatterjee
CSChristina F. Spiropoulou
Christina F. Spiropoulou
SBSina Bavari
Sina Bavari
Katherine Seley-RadtkeKatherine Seley-Radtke
Katherine Seley-Radtke